Live feed
Filing
SC 13D/A
SC 13D/A0000899140-16-001496·Aegerion Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
Aegerion Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 00767E102
Event date: 2016-06-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,649,000
- Percent of class
- 8.9800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-16-001496
- Form type
- SC 13D/A
- Filer
- Aegerion Pharmaceuticals, Inc.
- CIK
- CIK 1338042
- Filed
- Jun 16, 2016
- Reporting period
- Jun 14, 2016
- Description
- Schedule 13D beneficial ownership